BioPharma Bitez: AstraZeneca, Axovant, and more!

Welcome back everybody to another edition of “BioPharma Bitez,” the top news in the industry as well as one story outside of it. So, to… Read more

BioPharma Bitez: Alkermes, Merck, UniQure, and more!

Welcome back everybody to another edition of “BioPharma Bitez” the top news in the industry as well as one story outside of it. So, kicking… Read more

BioPharma Bitez: Roche, Voyage, UK Biotechs and more!

Welcome back everybody to another edition of “BioPharma Bitez” the top news in the industry as well as one story outside of it. So, kicking… Read more

BioPharma Bitez: Celgene, CRISPR, Editas and more!

Welcome back everybody to another edition of “BioPharma Bitez,” the top news in the industry as well as one story outside of it. And stick… Read more

BioPharma Bitez: Verona, Aptinyx, and more!

Happy Friday everybody, welcome to this week’s edition of “BioPharma Bitez.” Top news in the industry as well as one story outside of it. Now,… Read more

BioPharma Bitez: Novartis, Takeda and more!

Happy Friday everybody, welcome to this week’s edition of “BioPharma Bitez.” The tops news in the industry as well as one story outside of it.… Read more

BioPharma Bitez: GSK, Vanda, Abbvie, and more!

Happy Friday everybody! Welcome to this week’s edition of “BioPharma Bitez”, the top news of the industry as well as one outside of it. So,… Read more

BioPharma Bitez: Nestle, Moderna, and Stan Lee

Happy Friday everybody. Welcome to this week’s edition of “BioPharma Bitez.” Top news in the industry as well as one story outside of it. So,… Read more

BioPharma Bitez: AstraZeneca, Biogen, and more!

Happy Friday everybody, welcome to this week’s episode of “BioPharma Bitez,” the top news of the industry, as well as one interesting story outside of… Read more

How Can We Hire and Develop Talent to Keep Up With Emerging Technologies?

 During the first week of last June, I had the opportunity to attend BIO 2018. While I was there, I noticed a worrying trend… Read more